Alphatec Holdings, Inc. (ATEC)

Market Cap	1.68B
Revenue (ttm)	482.26M
Net Income (ttm)	-186.64M
Shares Out	137.98M
EPS (ttm)	-1.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	339,704
Open	12.51
Previous Close	12.74
Day's Range	12.19 - 12.62
52-Week Range	8.66 - 19.14
Beta	1.47
Analysts	Strong Buy
Price Target	23.13 (+89.44%)
Earnings Date	May 7, 2024

About ATEC

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 2, 2006
• Employees: 839
• Stock Exchange: NASDAQ
• Ticker Symbol: ATEC

Financial Performance

In 2023, ATEC's revenue was $482.26 million, an increase of 37.45% compared to the previous year's $350.87 million. Losses were -$186.64 million, 23.4% more than in 2022.

Analyst Forecast

According to 8 analysts, the average rating for ATEC stock is "Strong Buy." The 12-month stock price forecast is $23.13, which is an increase of 89.44% from the latest price.

Price Target

$23.13

(89.44% upside)

Analyst Consensus: Strong Buy